Matthew McManus
Geschäftsführer bei BIO-TECHNE CORPORATION
Aktive Positionen von Matthew McManus
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIO-TECHNE CORPORATION | Geschäftsführer | 01.02.2024 | - |
Corporate Officer/Principal | 08.01.2024 | 01.02.2024 | |
Ansa Biotechnologies, Inc.
Ansa Biotechnologies, Inc. BiotechnologyHealth Technology Ansa Biotechnologies, Inc. develops novel DNA synthesis technology. The company is headquartered in Berkeley, CA. | Vorsitzender | 22.02.2023 | - |
Independent Dir/Board Member | 22.02.2023 | - |
Karriereverlauf von Matthew McManus
Ehemalige bekannte Positionen von Matthew McManus
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AZENTA, INC. | Geschäftsführer | 17.01.2022 | 14.10.2022 |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Direktor/Vorstandsmitglied | 05.08.2014 | 01.04.2021 |
Vorstandsvorsitzender | 05.08.2014 | - | |
Corporate Officer/Principal | - | 01.04.2021 | |
Präsident | 05.08.2014 | - | |
The Cleveland Clinic Foundation
The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services The Cleveland Clinic Foundation operates as a non-profit academic, research, and medical center. It offers clinic and hospital care with research and education services. The company was founded by Charles Posternack, George W. Crile, Frank E. Bunts, William E. Lower and John Phillips on February,5 1921 and is headquartered in Cleveland, OH. | Corporate Officer/Principal | 02.01.2010 | 02.01.2010 |
PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | - | - |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology PrimeraDx, Inc. develops and commercializes molecular diagnostics systems. It offers ICEPlex System, an open platform that allows clinical researchers to design their assays for the development of multiplexed, multimodal, and quantitative in vitro diagnostic to simultaneously interrogate dozens of biomarkers in the same reaction. The company's ICEPlex System also enables to design complex multi-modal assays that test for disparate target types, such as SNPs, expression biomarkers, miRNAs, and fusion genes, as well as addresses research challenges in oncology, infectious diseases, translational medicine research, and pharma quality control. It also focuses on developing oncology products that are intended to support cancer research, diagnostics, and therapeutics; and companion diagnostics solutions that help pharmaceutical companies to design, develop, and validate custom CDx tests. The company was founded by Vladimir I. Slepnev in 2004 and is headquartered in Mansfield, MA. | Direktor/Vorstandsmitglied | 20.09.2010 | - |
Vorstandsvorsitzender | 25.08.2010 | - | |
Präsident | 25.08.2010 | - |
Ausbildung von Matthew McManus
College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Boston College | Masters Business Admin |
University of Pennsylvania Medical Center | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 13 |
Operativ
Corporate Officer/Principal | 6 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Health Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
BIO-TECHNE CORPORATION | Health Technology |
AZENTA, INC. | Health Services |
Private Unternehmen | 6 |
---|---|
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology PrimeraDx, Inc. develops and commercializes molecular diagnostics systems. It offers ICEPlex System, an open platform that allows clinical researchers to design their assays for the development of multiplexed, multimodal, and quantitative in vitro diagnostic to simultaneously interrogate dozens of biomarkers in the same reaction. The company's ICEPlex System also enables to design complex multi-modal assays that test for disparate target types, such as SNPs, expression biomarkers, miRNAs, and fusion genes, as well as addresses research challenges in oncology, infectious diseases, translational medicine research, and pharma quality control. It also focuses on developing oncology products that are intended to support cancer research, diagnostics, and therapeutics; and companion diagnostics solutions that help pharmaceutical companies to design, develop, and validate custom CDx tests. The company was founded by Vladimir I. Slepnev in 2004 and is headquartered in Mansfield, MA. | Health Technology |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
The Cleveland Clinic Foundation
The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services The Cleveland Clinic Foundation operates as a non-profit academic, research, and medical center. It offers clinic and hospital care with research and education services. The company was founded by Charles Posternack, George W. Crile, Frank E. Bunts, William E. Lower and John Phillips on February,5 1921 and is headquartered in Cleveland, OH. | Health Services |
Ansa Biotechnologies, Inc.
Ansa Biotechnologies, Inc. BiotechnologyHealth Technology Ansa Biotechnologies, Inc. develops novel DNA synthesis technology. The company is headquartered in Berkeley, CA. | Health Technology |
- Börse
- Insiders
- Matthew McManus
- Erfahrung